1: Noncontraceptive Benefits Flashcards Preview

Simmons NURP 531 Exam 1 > 1: Noncontraceptive Benefits > Flashcards

Flashcards in 1: Noncontraceptive Benefits Deck (12)
Loading flashcards...
1
Q
  • There is a decreased risk of ovarian cancer.
  • Lower risk of PID.
A

Female Sterilization

2
Q

It is theoretically plausible that the noncontraceptive benefits of COCs may be realized with these methods as well.

A
  1. Patch
  2. Vaginal Ring
3
Q
  • Protection from STIs.
  • Do not appear to offer protection against human papillomavirus (HPV) infection.
  • Use is associated with higher rates of cervical intraepithelial neoplasia regression and cervical HPV infection clearance.
A

Male Condoms

4
Q
  • Menstrual flow is reduced by as much as 90%. FDA approved to treat heavy menstrual bleeding.
  • Can be used to treat idiopathic menorrhagia as well as heavy menstrual bleeding associated with perimenopause, uterine fibroids, and adenomyosis.
  • May also be useful in the treatment of endometrial hyperplasia, endometriosis, and dysmenorrhea.
  • Reduced risks of endometrial cancer and cervical cancer.
  • Protects the endometrium.
  • Can be used in a women’s late reproductive years and then left in place through the transition to menopause.
A

Progestin / Levonorgestrel IUDs (Mirena, Skyla, Liletta)

5
Q
  • Decreased risk of ovarian, endometrial, and breast cancers.
  • Numerous benefits for infant health.
A

Lactational Amenorrhea (Breastfeeding)

6
Q
  • Likely to improve menstrual symptoms, including dysmenorrhea, menorrhagia, premenstrual syndrome, and anemia.
  • The thickening of cervical mucus seen with progestin methods is protective against PID.
  • Reduction in seizures and sickle-cell crises.
  • Not affected by any medications except aminoglutethimide, which is used to treat Cushing’s disease.
A

Depot medroxyprogesterone acetate injection (DMPA or Depo-Provera)

7
Q

Can be used as emergency contraception and then left in place for birth control.

A

Copper IUD (T380A, Paragard)

8
Q
  • Future fertility may be preserved through the decreased risk of pelvic inflammatory disease and ectopic pregnancy.
  • Decreased risk of several cancers (colon, ovarian, and endometrial).
  • Decreased risk of the serious diseases of endometriosis, adenomyosis, rheumatoid arthritis, and asthma.
  • Protection against ovarian and uterine cancer may persist as long as 28 years after discontinuation of use of these methods.
  • The preservation of bone density that occurs in ever-users may persist up to age 80.
  • No increased risk of breast cancer.
  • Improvement in acne and hirsutism, and reduced incidence of benign breast conditions.
  • Regular periods, lighter periods (decrease anemia), decreases in mittelschmerz, dysmenorrhea, endometriosis, premenstrual symptoms, and the vasomotor symptoms of perimenopause.
A

COCs

9
Q

Has possible or theoretical value in protecting the cervix from infection (the only barrier methods known to reduce STIs are male and female condoms).

A
  1. Diaphragms
  2. Cervical Caps
10
Q
  • Likely to improve menstrual symptoms, including dysmenorrhea, menorrhagia, premenstrual syndrome, and anemia.
  • The thickening of cervical mucus seen with progestin methods is protective against PID.
A

POPs

11
Q

It can also be used to conceive when couples decide they want children.

A

Fertility Awareness Based (FAB)

12
Q
  • Likely to improve menstrual symptoms, including dysmenorrhea, menorrhagia, premenstrual syndrome, and anemia.
  • The thickening of cervical mucus seen with progestin methods is protective against PID.
  • Can decrease dysmenorrhea and endometriosis symptoms.
A

Subdermal Implant (Implanon, Nexplanon [newer])